Tue, Jul 21, 2026
A A A
Welcome Guest
Free Trial RSS pod
Get FREE trial access to our award winning publications
Industry Updates

NEXTHERA adds former Citadel Portfolio Manager, Rael Mazansky

Thursday, March 30, 2017
Opalesque Industry Update - NEXTHERA Capital, a hedge fund manager concentrating in global therapeutics, announced the addition of Rael Mazansky M.D. to serve as Director of Research.

Working with NEXTHERA's co-Founder and CIO, Ori Hershkovitz, Mazansky will help drive NEXTHERA's investment strategy of seeking high risk-adjusted returns from the healthcare and therapeutics sectors.

NEXTHERA is a NY based fundamental long/short equity fund concentrating in global therapeutics (large cap pharmaceuticals, specialty pharmaceuticals/generics, and biotech). The firm was founded by Ori Hershkovitz, formerly head of pharmaceutical research at Sphera Funds Management, Israel's largest hedge fund, and is a top authority on Teva (in and out of Israel), alongside Daniel Malek, who was previously allocating capital to external managers at EJS Investment S.A.

"We are excited to hire an individual with a long and impressive history in healthcare investing. Rael will strengthen our team as we continue to develop the best human capital to produce innovative research and guidance for the portfolio," said Daniel Malek, co-Founder and CEO. "Rael's experience and perspective will help NEXTHERA attempt to capitalize on dynamic opportunities in this often misunderstood and complex area."

Mazansky joins NEXTHERA after being a healthcare portfolio manager at Surveyor Capital (Citadel), and previously holding senior biotech analyst roles at Perceptive Advisors and Ridgeback Capital.

Article link

What do you think?
   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Previous Opalesque Exclusives                                  
Previous Other Voices                                               
Access Alternative Market Briefing

 



  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Other Voices: Nvidia extraordinary growth and the challenge of sustaining demanding valuations over time[more]

    Antonio Di Giacomo, Senior Market Analyst at XS.com, writes: Nvidia has established itself as one of the most extraordinary growth companies in the global technology sector. Over the past two fiscal years, its revenues have risen from levels close to $60 billion annually to well above $120 billi

  2. Secondaries take center stage: What the 2026 PE landscape means for GPs and investors[more]

    Matthias Knab, Opalesque for New Managers: The 2026 edition of Dechert's Global Private Equity Outlook - "Signs of a Gradual Thaw" - marks a notable shift in industry sentiment. After years of compr

  3. And, finally: Time to share it with the people[more]

    From Newsoftheweird: Leavenworth, Washington, has become a tourist destination because of the Bavarian theme businesses have adopted there, NPR reported. One shop, the Leavenworth Nutcracker Museum, houses the world's largest nutcracker collection, thanks to 101-year-old Arlene Wagner. Wagner sta

  4. Opalesque Exclusive: Private Markets Evergreen Funds - An Insider's View[more]

    Matthias Knab, Opalesque for New Managers: Private Markets Evergreen Funds: What Investors Need to Know Before They Dive In The democratization of private markets is well underway. Structural barriers t

  5. Opalesque Exclusive: Governance, Scale, and Boutique Resilience in a Consolidating Hedge Fund Industry[more]

    Matthias Knab, Opalesque for New Managers: The hedge fund industry has undergone significant consolidation in recent years, with capital increasingly concentrated among large multi-strategy platforms. Yet boutique m

Click here for More about Opalesque Tracking
- A new, unique Premium Service -
  1. TOMS
  2. CIFC
  3. Orion Commodities
  4. Zimmer Partners
  5. Banor
  1. mortgage fund
  2. fund manager
  3. new fund launch
  4. outsource
  5. turkey